Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Massachusetts General Hospital, Mass General Brigham, Institut Gustave Roussy, Inserm, University of Sydney, Royal North Shore Hospital, Mount Vernon Cancer Centre, National Cancer Research Institute, University Children's Hospital Tübingen, University of Iowa Hospitals and Clinics, Russian Cancer Research Center NN Blokhin, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, The Maria Sklodowska-Curie National Research Institute of Oncology, Elbe Kliniken Stade-Buxtehude, University Hospital of Zurich, Charité - Universitätsmedizin Berlin, Royal Marsden Hospital, University Medical Center, University Hospital and Clinics, German Cancer Research Center, Centre Hospitalier Universitaire de Nantes, Oslo University Hospital, National Institute for Health Research, Churchill Hospital, NIHR Biomedical Research Centre at The Royal Marsden and the ICR, Austrian Society of Dermatology and Venereology, GlaxoSmithKline (United States), Essen University Hospital